Did you know that it’s been 20 years since GE Healthcare introduced the first SPECT/CT system? We brought the latest in SPECT/CT advancements to a wider range of clinical environments with the scalable 800 Series now available in Europe.
NM 830 for improved sensitivity with LEHRS collimator compared to LEHR,
NM/CT 850 for low-dose attenuation correction and localization,
NM/CT 860 for increased procedure volume with a standalone diagnostic CT,
NM/CT 870 DR digital ready, for a more comfortable experience and exceptional IQ,
NM/CT 870 CZT digital, for excellent spatial and ultra-high energy resolutions
and a new nuclear medicine workstation, Xeleris 4 DR - all designed to achieve exceptional outcomes.
For the first time in Europe, you will be able to see the 3rd generation of SPECT/CT.
Visit us @ EANM in Düsseldorf, Booth 4, Hall 4, October 12‑17 to learn more about the 800 Series.
1. Compared to LEHR collimator, with Step & Shoot scan mode (for SPECT) / without Clarity 2D (for Planar). As demonstrated in phantom testing using a bone scan protocol, Evolution processing (for SPECT), and a model observer. Because model observer results may not always match those from a human reader, the actual time/dose reduction depends on the clinical task, patient size, anatomical location and clinical practice. A radiologist should determine the appropriate scan time/dose for the particular clinical task.